Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

0.1821
-0.0249-12.03%
Post-market: 0.19000.0079+4.34%19:45 EDT
Volume:1.76M
Turnover:336.32K
Market Cap:22.76M
PE:-0.13
High:0.2119
Open:0.2033
Low:0.1813
Close:0.2070
Loading ...
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 14, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 19, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 19, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 03, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2021

Correspondence

CORRESP [Cover] - Correspondence